Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per shar
-
Shares outstanding
-
22,457,615
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-496,945
-
Total reported value, excl. options
-
$0
-
Value change
-
-$120,193
-
Number of sells
-
-12
Significant Holders of Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) as of Q3 2025
12 filings reported holding VTAK - Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar as of Q3 2025.
Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 22,457,615 outstanding shares and own 0% of the company stock.
Largest 10 shareholders include HARBOUR INVESTMENTS, INC. (0 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), SBI Securities Co., Ltd. (0 shares), Ground Swell Capital, LLC (0 shares), RENAISSANCE TECHNOLOGIES LLC (0 shares), UBS Group AG (0 shares), BANK OF AMERICA CORP /DE/ (0 shares), RAYMOND JAMES FINANCIAL INC (0 shares), GOLDMAN SACHS GROUP INC (0 shares), and CITADEL ADVISORS LLC (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.